Evidence map›Paper›PMID 30358041›Full record

ArticleChembiochem : a European journal of chemical biology2019

Photoinducible Oncometabolite Detection.

Rhushikesh A Kulkarni, Chloe A Briney, Daniel R Crooks, Sarah E Bergholtz, Chandrasekhar Mushti, Stephen J Lockett, Andrew N Lane, Teresa W-M Fan, Rolf E Swenson, W Marston Linehan and 1 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Light-Triggered Click Chemistry.Chemical reviews · 2021
    Review
  4. Bioorthogonal chemistry.Nature reviews. Methods primers · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Epigenetic regulation by endogenous metabolite pharmacology.Current opinion in chemical biology · 2019
    Review
  9. Bioorthogonal oncometabolite ligation.Methods in enzymology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rhushikesh A KulkarniChemical Biology Laboratory, National Cancer Institute, NIH, Frederick, MD, 21702, USA.ORCID 0000-0002-6786-9996
Chloe A BrineyChemical Biology Laboratory, National Cancer Institute, NIH, Frederick, MD, 21702, USA.
Daniel R CrooksUrologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, 20817, USA.
Sarah E BergholtzChemical Biology Laboratory, National Cancer Institute, NIH, Frederick, MD, 21702, USA.
Chandrasekhar MushtiImaging Probe Development Center, National Heart Lung and Blood Institute, NIH, Rockville, MD, 20850, USA.
Stephen J LockettOptical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21702, USA.
Andrew N LaneCenter for Environmental and Systems Biochemistry, Department of Toxicology and Cancer Biology, and, Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
Teresa W-M FanCenter for Environmental and Systems Biochemistry, Department of Toxicology and Cancer Biology, and, Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
Rolf E SwensonImaging Probe Development Center, National Heart Lung and Blood Institute, NIH, Rockville, MD, 20850, USA.
W Marston LinehanUrologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, 20817, USA.
Jordan L MeierChemical Biology Laboratory, National Cancer Institute, NIH, Frederick, MD, 21702, USA.ORCID 0000-0002-0537-7101

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Imaging Probe Development CenterZICHL005090 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SWENSON, ROLF · 2011 to 2025
$22.2M
Targeting Cancer Through Modifications and MetabolismZIABC011488 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MEIER, JORDAN L · 2013 to 2025
$21.3M
Intramural NIH HHS ZIA BC011488NCI NIH HHS P30 CA177558NCI NIH HHS ZIA BC011488
6 · The paper itself

Abstract

Dysregulated metabolism can fuel cancer by altering the production of bioenergetic building blocks and directly stimulating oncogenic gene-expression programs. However, relatively few optical methods for the direct study of metabolites in cells exist. To address this need and facilitate new approaches to cancer treatment and diagnosis, herein we report an optimized chemical approach to detect the oncometabolite fumarate. Our strategy employs diaryl tetrazoles as cell-permeable photoinducible precursors to nitrileimines. Uncaging these species in cells and cell extracts enables them to undergo 1,3-dipolar cycloadditions with endogenous dipolarophile metabolites such as fumarate to form pyrazoline cycloadducts that can be readily detected by their intrinsic fluorescence. The ability to photolytically uncage diaryl tetrazoles provides greatly improved sensitivity relative to previous methods, and enables the facile detection of dysregulated fumarate metabolism through biochemical activity assays, intracellular imaging, and flow cytometry. Our studies showcase an intersection of bioorthogonal chemistry and metabolite reactivity that can be applied for biological profiling, imaging, and diagnostics.

Indexed as

FluorescenceCell LineFluorescent DyesFumaratesHumansMicroscopy, ConfocalMolecular StructureOptical ImagingTetrazolesFluorescent DyesFumaratesTetrazolesbioorthogonal chemistrycycloadditionepigeneticsfluorescent detectionmetabolism

Identifiers

PMID30358041
PMCPMC8141106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.